From USFDA
SMS Pharmaceuticals has received Establishment Inspection Report from USFDA for its manufacturing facility - Unit II located at Bachupally, Hyderabad, Telangana.The facility was inspected in November 2017 and there were no Form 483 observations during the inspection.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)